Immucell (ICCC) Depreciation & Amortization (CF) (2024 - 2026)

Immucell (ICCC) has reported Depreciation & Amortization (CF) for 3 consecutive years, with $470621.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 30.69% year-over-year to $470621.0; the trailing twelve-month figure through Jun 2026 stood at $2.6 million (up 25.28% YoY), and the FY2025 full-year result was $2.8 million, up 1.98% from the prior year.
• Depreciation & Amortization (CF) fell to $470621.0 in Q2 2026 per ICCC's latest filing, from $709472.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $709472.0 in Q4 2025 and bottomed at $470621.0 in Q2 2026.
• Historically, Depreciation & Amortization (CF) has averaged $656396.5 across 3 years, with a median of $685291.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) advanced 3.62% in 2025, then tumbled 30.69% in 2026.
• Over 3 years, Depreciation & Amortization (CF) stood at $684655.0 in 2024, then climbed by 3.62% to $709472.0 in 2025, then plunged by 33.67% to $470621.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $470621.0, $709472.0, and $708667.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.